Phase 4 ADHD Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You must be willing to follow all study requirements and be available for the full length of the study.
• Children and teenagers between the ages of 6 and 17 years old (at the time of signing up) may be eligible.
• The child must be able to swallow liquid medication by mouth.
• English must be the child's main language.
• The child must meet the criteria for ADHD (hyperactive type, inattentive type, or combined type) based on a structured interview called the KSADS.
• The child must also meet the criteria for ADHD based on a questionnaire called the Vanderbilt, either now or in the past, as reported by a teacher or other professional.

Who may not be able to join:

• Children who are currently taking ADHD medication (stimulant or non-stimulant) and are not willing to stop taking it for at least 3 days before the study starts.
• Children who have been diagnosed with psychosis or bipolar disorder, based on an interview with a parent.
• Children who have a history of a serious head injury with loss of consciousness, epilepsy, or any other brain condition that could affect how the brain works.
• Children with certain heart conditions, including an abnormal heart rhythm reading on an ECG, a heart rate or blood pressure that is unusually high for their age, certain structural heart problems detected by heart scan (ECHO), a history of sudden cardiac arrest or unexplained fainting, or the use of a pacemaker (confirm with trial site for full list of specific heart conditions).
• Children with certain other heart findings on ECG may still be able to join but must first be assessed by a heart doctor (cardiologist) before starting the study (confirm with trial site).
• Children who are currently taking a type of medication called a monoamine oxidase inhibitor (MAOI), or who have taken one within the last 14 days.
• Children who are currently in the process of having their dose adjusted for any non-ADHD psychiatric medication — however, children on a stable dose of such medication (no changes for at least 4 weeks) may still be eligible.
• Children who are known to be allergic or sensitive to methylphenidate (the active drug being studied) or to bananas, as banana flavoring is used in the study medication.
• Children with severe obstructive sleep apnea (a serious breathing condition during sleep), rated at a severity level of 4 on the McGill scale.
• Girls who are pregnant — a pregnancy test will be done at the medical screening for any female participant who has started their menstrual cycle, and those who are pregnant will not be able to join.

Important: Always verify eligibility with the trial site directly before applying.